DURHAM, NC, March 16 - The term ‘regulanomics,’ which refers to the field of gene regulation, may never catch on the way that ‘genomics’ or ‘proteomics’ has. But Thomas Werner, CEO of the Munich-based startup Genomatix, is betting that this field has already taken off.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

NPR reports that with medical data being big business, some companies want to get patients involved.

The Asbury Park Press reports on the startup Genomic Prediction's test to determine an embryo's risk of disease.

In PNAS this week: optical mapping allows glimpse of structural variants, disease-linked GATA2 mutations boosts its protein activity, and more.

Senator Elizabeth Warren (D-Mass.) has released the results of a genetic ancestry analysis, the Boston Globe reports.